Global, regional, and national cancer deaths and disability-adjusted life-years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990-2019.


Journal

Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236

Informations de publication

Date de publication:
01 05 2022
Historique:
revised: 15 12 2021
received: 13 08 2021
accepted: 17 12 2021
pubmed: 4 3 2022
medline: 13 4 2022
entrez: 3 3 2022
Statut: ppublish

Résumé

Alcohol consumption is a risk factor for a number of communicable and non-communicable diseases, including several types of cancer. This article reports the burden of cancers attributable to alcohol consumption by age, sex, location, sociodemographic index (SDI), and cancer type from 1990 to 2019. The Comparative Risk Assessment approach was used in the 2019 Global Burden of Disease study to report the burden of cancers attributable to alcohol consumption between 1990 and 2019. In 2019, there were globally an estimated 494.7 thousand cancer deaths (95% uncertainty interval [UI], 439.7 to 554.1) and 13.0 million cancer disability-adjusted life-years (DALYs; 95% UI, 11.6 to 14.5) that were attributable to alcohol consumption. The alcohol-attributable DALYs were much higher in men (10.5 million; 95% UI, 9.2 to 11.8) than women (2.5 million; 95% UI, 2.2 to 2.9). The global age-standardized death and DALY rates of cancers attributable to alcohol decreased by 14.7% (95% UI, 6.4% to 23%) and 18.1% (95% UI, 9.2% to 26.5%), respectively, over the study period. Central Europe had the highest age-standardized death rates that were attributable to alcohol consumption(10.3; 95% UI, 8.7 to12.0). Moreover, there was an overall positive association between SDI and the regional age-standardized DALY rate for alcohol-attributable cancers. Despite decreases in age-standardized deaths and DALYs, substantial numbers of cancer deaths and DALYs are still attributable to alcohol consumption. Because there is a higher burden in males, the elderly, and developed regions (based on SDI), these groups and regions should be prioritized in any prevention programs.

Sections du résumé

BACKGROUND
Alcohol consumption is a risk factor for a number of communicable and non-communicable diseases, including several types of cancer. This article reports the burden of cancers attributable to alcohol consumption by age, sex, location, sociodemographic index (SDI), and cancer type from 1990 to 2019.
METHODS
The Comparative Risk Assessment approach was used in the 2019 Global Burden of Disease study to report the burden of cancers attributable to alcohol consumption between 1990 and 2019.
RESULTS
In 2019, there were globally an estimated 494.7 thousand cancer deaths (95% uncertainty interval [UI], 439.7 to 554.1) and 13.0 million cancer disability-adjusted life-years (DALYs; 95% UI, 11.6 to 14.5) that were attributable to alcohol consumption. The alcohol-attributable DALYs were much higher in men (10.5 million; 95% UI, 9.2 to 11.8) than women (2.5 million; 95% UI, 2.2 to 2.9). The global age-standardized death and DALY rates of cancers attributable to alcohol decreased by 14.7% (95% UI, 6.4% to 23%) and 18.1% (95% UI, 9.2% to 26.5%), respectively, over the study period. Central Europe had the highest age-standardized death rates that were attributable to alcohol consumption(10.3; 95% UI, 8.7 to12.0). Moreover, there was an overall positive association between SDI and the regional age-standardized DALY rate for alcohol-attributable cancers.
CONCLUSIONS
Despite decreases in age-standardized deaths and DALYs, substantial numbers of cancer deaths and DALYs are still attributable to alcohol consumption. Because there is a higher burden in males, the elderly, and developed regions (based on SDI), these groups and regions should be prioritized in any prevention programs.

Identifiants

pubmed: 35239973
doi: 10.1002/cncr.34111
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1840-1852

Informations de copyright

© 2022 American Cancer Society.

Références

Burton R, Sheron N. No level of alcohol consumption improves health. Lancet. 2018;392:987-988. doi:10.1016/s0140-6736(18)31571-x
Liang W, Chikritzhs T. Reduction in alcohol consumption and health status. Addiction. 2011;106:75-81. doi:10.1111/j.1360-0443.2010.03164.x
Rehm J, Baliunas D, Borges GLG, et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction. 2010;105:817-843. doi:10.1111/j.1360-0443.2010.02899.x
Balsa AI, Giuliano LM, French MT. The effects of alcohol use on academic achievement in high school. Econ Educ Rev. 2011;30:1-15. doi:10.1016/j.econedurev.2010.06.015
Thørrisen MM, Bonsaksen T, Hashemi N, Kjeken I, van Mechelen W, Aas RW. Association between alcohol consumption and impaired work performance (presenteeism): a systematic review. BMJ Open. 2019;9:e029184. doi:10.1136/bmjopen-2019-029184
Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:1015-1035. doi:10.1016/s0140-6736(18)31310-2
Rehm J, Shield KD, Weiderpass E. Alcohol consumption. A leading risk factor for cancer. Chem Biol Interact. 2020;331:109280. doi:10.1016/j.cbi.2020.109280
Schütze M, Boeing H, Pischon T, et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ. 2011;342:d1584. doi:10.1136/bmj.d1584
Michaud DS, Vrieling A, Jiao L, et al. Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control. 2010;21:1213-1225. doi:10.1007/s10552-010-9548-z
Kunzmann AT, Coleman HG, Huang WY, Berndt SI. The association of lifetime alcohol use with mortality and cancer risk in older adults: a cohort study. PLoS Med. 2018;15:e1002585. doi:10.1371/journal.pmed.1002585
Choi Y-J, Myung S-K, Lee J-H. Light alcohol drinking and risk of cancer: a meta-analysis of cohort studies. Cancer Res Treat. 2018;50:474-487. doi:10.4143/crt.2017.094
Accelerating action to reduce the harmful use of alcohol. World Health Organization. Published February 7, 2020. https://apps.who.int/gb/ebwha/pdf_files/EB146/B146(14)-en.pdf
Rumgay H, Shield K, Charvat H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021;22:1071-1080. doi:10.1016/s1470-2045(21)00279-5
Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204-1222. doi:10.1016/s0140-6736(20)30925-9
Murray CJ, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223-1249.
Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784-1793. doi:10.1016/s0140-6736(05)67725-2
Holmes J, Beard E, Brown J, et al. Effects on alcohol consumption of announcing and implementing revised UK low-risk drinking guidelines: findings from an interrupted time series analysis. J Epidemiol Community Health. 2020;74:942. doi:10.1136/jech-2020-213820
Bowden JA, Delfabbro P, Room R, Miller CL, Wilson C. Alcohol consumption and NHMRC guidelines: has the message got out, are people conforming and are they aware that alcohol causes cancer? Aust N Z J Public Health. 2014;38:66-72. doi:10.1111/1753-6405.12159
Shield K, Manthey J, Rylett M, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health. 2020;5:e51-e61. doi:10.1016/s2468-2667(19)30231-2
Rehm J, Shield KD. Alcohol use and cancer in the European Union. Eur Addict Res. 2021;27:1-8. doi:10.1159/000507017
Epidemiology of alcohol use in the WHO South-East Asia Region. World Health Organization. Accessed July 7, 2021. https://apps.who.int/iris/handle/10665/259831
Park S, Shin H-R, Lee B, et al. Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea. BMC Cancer. 2014;14:420. doi:10.1186/1471-2407-14-420
Hong SA, Peltzer K. Early adolescent patterns of alcohol and tobacco use in eight Association of South-East Asian Nations (ASEAN) member states. Subst Use Misuse. 2019;54:288-296. doi:10.1080/10826084.2018.1517797
Petti S, Masood M, Scully C. The magnitude of tobacco smoking-betel quid chewing-alcohol drinking interaction effect on oral cancer in South-East Asia. A meta-analysis of observational studies. PLoS One. 2013;8:e78999. doi:10.1371/journal.pone.0078999
Culberson JW. Alcohol use in the elderly: beyond the CAGE. Part 2: screening instruments and treatment strategies. Geriatrics. 2006;61:20-26.
Kalapatapu RK, Paris P, Neugroschl JA. Alcohol use disorders in geriatrics. Int J Psychiatry Med. 2010;40:321-337. doi:10.2190/pm.40.3.g
Kwasnicka D, Dombrowski SU, White M, Sniehotta F. Theoretical explanations for maintenance of behaviour change: a systematic review of behaviour theories. Health Psychol Rev. 2016;10:277-296. doi:10.1080/17437199.2016.1151372
Patel P, Kaiser BN, Meade CS, Giusto A, Ayuku D, Puffer E. Problematic alcohol use among fathers in Kenya: poverty, people, and practices as barriers and facilitators to help acceptance. Int J Drug Policy. 2020;75:102576. doi:10.1016/j.drugpo.2019.10.003
Getty C-A, Morande A, Lynskey M, Weaver T, Metrebian N. Mobile telephone-delivered contingency management interventions promoting behaviour change in individuals with substance use disorders: a meta-analysis. Addiction. 2019;114:1915-1925. doi:10.1111/add.14725
Taylor B, Rehm J. Moderate alcohol consumption and diseases of the gastrointestinal system: a review of pathophysiological processes. Dig Dis. 2005;23:177-180. doi:10.1159/000090164
Stanculeanu DL, Daniela Z, Lazescu A, Bunghez R, Anghel R. Development of new immunotherapy treatments in different cancer types. J Med Life. 2016;9:240-248.
Ramjaun A, Nassif MO, Krotneva S, Huang AR, Meguerditchian AN. Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment. J Geriatr Oncol. 2013;4:271-281. doi:10.1016/j.jgo.2013.04.002
Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383:640-649. doi:10.1056/nejmoa1916623
Birnbaum J, Gadi VK, Markowitz E, Etzioni R. The effect of treatment advances on the mortality results of breast cancer screening trials: a microsimulation model. Ann Intern Med. 2016;164:236-243. doi:10.7326/m15-0754
Hendrick RE, Baker JA, Helvie MA. Breast cancer deaths averted over 3 decades. Cancer. 2019;125:1482-1488. doi:10.1002/cncr.31954
Sovich JL, Sartor Z, Misra S. Developments in screening tests and strategies for colorectal cancer. Biomed Res Int. 2015;2015:326728. doi:10.1155/2015/326728
Procaccio L, Schirripa M, Fassan M, et al. Immunotherapy in gastrointestinal cancers. Biomed Res Int. 2017;2017:4346576. doi:10.1155/2017/4346576
Elder RW, Lawrence B, Ferguson A, et al. The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms. Am J Prev Med. 2010;38:217-229. doi:10.1016/j.amepre.2009.11.005
Cobiac L, Vos T, Doran C, Wallace A. Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia. Addiction. 2009;104:1646-1655. doi:10.1111/j.1360-0443.2009.02708.x
Pados E, Kovács A, Kiss D, et al. Voices of temporary sobriety-a diary study of an alcohol-free month in Hungary. Subst Use Misuse. 2020;55:839-850. doi:10.1080/10826084.2019.1705861
Yeomans H. New year, new you: a qualitative study of Dry January, self-formation and positive regulation. Drugs Educ Prev Policy. 2019;26:460-468. doi:10.1080/09687637.2018.1534944
de Visser RO, Piper R. Short- and longer-term benefits of temporary alcohol abstinence during ‘Dry January’ are not also observed among adult drinkers in the general population: prospective cohort study. Alcohol Alcohol. 2020;55:433-438. doi:10.1093/alcalc/agaa025
Znaor A, Eser S, Anton-Culver H, et al. Cancer surveillance in northern Africa, and central and western Asia: challenges and strategies in support of developing cancer registries. Lancet Oncol. 2018;19:e85-e92. doi:10.1016/s1470-2045(18)30019-6
Bray F, Znaor A, Cueva P, et al. Planning and Developing Population-Based Cancer Registration in Low- or Middle-Income Settings. International Agency for Research on Cancer; 2014.
Curado MP, Voti L, Sortino-Rachou AM. Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control. 2009;20:751-756. doi:10.1007/s10552-008-9288-5
Viner B, Barberio AM, Haig TR, Friedenreich CM, Brenner DR. The individual and combined effects of alcohol consumption and cigarette smoking on site-specific cancer risk in a prospective cohort of 26,607 adults: results from Alberta's Tomorrow Project. Cancer Causes Control. 2019;30:1313-1326. doi:10.1007/s10552-019-01226-7
Mello FW, Melo G, Pasetto JJ, Silva CAB, Warnakulasuriya S, Rivero ERC. The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis. Clin Oral Investig. 2019;23:2849-2859. doi:10.1007/s00784-019-02958-1

Auteurs

Saeid Safiri (S)

Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.

Seyed Aria Nejadghaderi (SA)

Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Nahid Karamzad (N)

Nutrition Research Center, Department of Biochemistry and Diet Therapy, School of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Kristin Carson-Chahhoud (K)

Australian Centre for Precision Health, University of South Australia, Adelaide, South Australia, Australia.
School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.

Nicola Luigi Bragazzi (NL)

Centre for Disease Modelling, York University, Toronto, Ontario, Canada.

Mark J M Sullman (MJM)

Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.
Department of Social Sciences, University of Nicosia, Nicosia, Cyprus.

Amir Almasi-Hashiani (A)

Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran.

Mohammad Ali Mansournia (MA)

Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Gary S Collins (GS)

Centre for Statistics in Medicine, NDORMS, Botnar Research Centre, University of Oxford, Oxford, United Kingdom.
NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Jay S Kaufman (JS)

Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Ali-Asghar Kolahi (AA)

Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH